TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive NCI Will Get $1.3 Billion, But Only If Congress Fends Off GRH Cuts, Reprogramming For Drug War October 3, 1986
TCL Archive Conference Bill Includes Funding For DOD For Breast, Prostate, Ovarian Cancer October 4, 1996
TCL Archive NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA. July 13, 2007
TCL Archive GAO Probes NCI Intramural Program, Finds All Is Well, But Won’t Report It October 22, 1982
TCL Archive Reviews of the Faculty Report by Irwin Krakoff, Robert Cook-Deegan, and Michael Katz March 29, 2013
